These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37421401)

  • 1. Imaging cardiac hypertrophy in hypertrophic cardiomyopathy and its differential diagnosis.
    Rashdan L; Hodovan J; Masri A
    Curr Opin Cardiol; 2023 Sep; 38(5):397-404. PubMed ID: 37421401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multi-modality cardiac imaging approach to the Athlete's heart: an expert consensus of the European Association of Cardiovascular Imaging.
    Galderisi M; Cardim N; D'Andrea A; Bruder O; Cosyns B; Davin L; Donal E; Edvardsen T; Freitas A; Habib G; Kitsiou A; Plein S; Petersen SE; Popescu BA; Schroeder S; Burgstahler C; Lancellotti P
    Eur Heart J Cardiovasc Imaging; 2015 Apr; 16(4):353. PubMed ID: 25681828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating the athlete's heart from hypertrophic cardiomyopathy.
    Wasfy MM; Weiner RB
    Curr Opin Cardiol; 2015 Sep; 30(5):500-5. PubMed ID: 26196658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging cardiac morphology in hypertrophic cardiomyopathy: recent advances.
    Reichek N
    Curr Opin Cardiol; 2015 Sep; 30(5):461-7. PubMed ID: 26154073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Texture analysis of T2-weighted cardiovascular magnetic resonance imaging to discriminate between cardiac amyloidosis and hypertrophic cardiomyopathy.
    Huang S; Shi K; Zhang Y; Yan WF; Guo YK; Li Y; Yang ZG
    BMC Cardiovasc Disord; 2022 May; 22(1):235. PubMed ID: 35597906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Athlete's heart or hypertrophic cardiomyopathy?
    Lauschke J; Maisch B
    Clin Res Cardiol; 2009 Feb; 98(2):80-8. PubMed ID: 18853091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
    Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
    Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac MR Imaging of Hypertrophic Cardiomyopathy: Techniques, Findings, and Clinical Relevance.
    Amano Y; Kitamura M; Takano H; Yanagisawa F; Tachi M; Suzuki Y; Kumita S; Takayama M
    Magn Reson Med Sci; 2018 Apr; 17(2):120-131. PubMed ID: 29343659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.
    Dohy Z; Szabo L; Toth A; Czimbalmos C; Horvath R; Horvath V; Suhai FI; Geller L; Merkely B; Vago H
    Int J Cardiovasc Imaging; 2021 Jun; 37(6):2027-2036. PubMed ID: 33555536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
    Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncontrast T1ρ dispersion imaging is sensitive to diffuse fibrosis: A cardiovascular magnetic resonance study at 3T in hypertrophic cardiomyopathy.
    Wang K; Zhang W; Li S; Jin H; Jin Y; Wang L; Li R; Yang Y; Zheng J; Cheng J
    Magn Reson Imaging; 2022 Sep; 91():1-8. PubMed ID: 35525524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Diagnosis of Thick Myocardium according to Histologic Features Revealed by Multiparametric Cardiac Magnetic Resonance Imaging.
    Cha MJ; Kim C; Park CH; Hong YJ; Shin JM; Kim TH; Cha YJ; Park CH
    Korean J Radiol; 2022 Jun; 23(6):581-597. PubMed ID: 35555885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of electrocardiographic changes and myocardial fibrosis in patients with hypertrophic cardiomyopathy detected by cardiac magnetic resonance imaging.
    Song BG; Yang HS; Hwang HK; Kang GH; Park YH; Chun WJ; Oh JH
    Clin Cardiol; 2013 Jan; 36(1):31-5. PubMed ID: 23070984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.